VERU INC. — Investor Relations & Filings
Filings indexed
1,019
across all filing types
Latest filing
2026-05-13
Regulatory Filings
Country
US
United States of America
Listing
US
VERU
Veru Inc. is a late-stage biopharmaceutical company focused on developing and commercializing treatments for cardiometabolic and inflammatory diseases. The company's primary development programs address high-quality weight loss and atherosclerotic coronary artery disease. Its lead candidate, enobosarm, is a novel, oral selective androgen receptor modulator (SARM) designed to prevent muscle loss in patients undergoing weight loss therapy with GLP-1 receptor agonists. Veru is also advancing sabizabulin, an oral broad anti-inflammatory agent, for the treatment of atherosclerotic coronary artery disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-8 - VERU INC. (0000863894) (Filer) | 2026-05-13 | English | |
| 10-Q - VERU INC. (0000863894) (Filer) | 2026-05-13 | English | |
| 8-K - VERU INC. (0000863894) (Filer) | 2026-05-13 | English | |
| Regulatory Filings 2026 | 2026-04-16 | English | |
| Regulatory Filings 2026 | 2026-04-16 | English | |
| S-3 - VERU INC. (0000863894) (Filer) | 2026-04-07 | English |
Browse filings by year
21 years- 2026 13 filings
- 2025 49 filings
- 2024 57 filings
- 2023 62 filings
- 2022 32 filings
- 2021 33 filings
- 2020 38 filings
- 2019 63 filings
- 2018 66 filings
- 2017 70 filings
- 2016 117 filings
- 2015 39 filings
- 2014 38 filings
- 2013 52 filings
- 2012 62 filings
- 2011 33 filings
- 2010 64 filings
- 2009 46 filings
- 2008 32 filings
- 2007 29 filings
- 2006 24 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 45613091 | S-8 - VERU INC. (0000863894) (Filer) | 2026-05-13 | English | ||
| 45609420 | 10-Q - VERU INC. (0000863894) (Filer) | 2026-05-13 | English | ||
| 45554255 | 8-K - VERU INC. (0000863894) (Filer) | 2026-05-13 | English | ||
| 46143701 | Regulatory Filings 2026 | 2026-04-16 | English | ||
| 46143704 | Regulatory Filings 2026 | 2026-04-16 | English | ||
| 33744290 | S-3 - VERU INC. (0000863894) (Filer) | 2026-04-07 | English | ||
| 46143716 | S-3 | 2026-04-07 | English | ||
| 46143719 | FORM 8-K | 2026-03-13 | English | ||
| 46143726 | Major Shareholding Notification 2026 | 2026-02-17 | English | ||
| 24551413 | 10-Q Filing | 2026-02-11 | English | ||
| 24551360 | 8-K Filing | 2026-02-11 | English | ||
| 46143735 | DEFA14A | 2026-01-28 | English | ||
| 24551362 | DEF 14A Filing | 2026-01-28 | English | ||
|
2025
2 filings
| |||||
| 24551568 | 10-K Filing | 2025-12-17 | English | ||
| 24551384 | 8-K Filing | 2025-12-17 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AVADEL PHARMACEUTICALS PLC
Biopharmaceutical company developing therapies for sleep di…
|
AVDL | US | Manufacturing |
|
Avagenesis Corp.
Develops automated technology for isolating and enriching r…
|
VVA | CA | Manufacturing |
|
Avalon GloboCare Corp.
Develops cell-based immunotherapies and provides precision …
|
ALBT | US | Manufacturing |
|
AVECHO BIOTECHNOLOGY LIMITED
Develops human and animal health products using TPM® drug d…
|
AVE | AU | Manufacturing |
|
Avicanna Inc.
Commercial-stage international biopharma focused on evidenc…
|
AVCN | CA | Manufacturing |
|
Avidity Biosciences, Inc.
Develops a class of RNA therapeutics called Antibody Oligon…
|
RNA | US | Manufacturing |
|
Avivagen Inc.
Developed natural health products and feed additives; filed…
|
VIV | CA | Manufacturing |
|
Awakn Life Sciences Corp. (1169082 BC Ltd.)
Clinical-stage biotech developing novel therapeutics, inclu…
|
AWKN | CA | Manufacturing |
|
Axcan Pharma Inc.
Specialty pharmaceutical company focused on prescription th…
|
AXCA | CA | Manufacturing |
|
Axogen, Inc.
Develops and commercializes surgical solutions for peripher…
|
AXGN | US | Manufacturing |
VERU INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34598/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34598 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34598 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34598 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34598}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for VERU INC. (id: 34598)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.